Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Nilotinib | 0.0033113 | uM | 4 | 312.50 | 138.79 | 304.00 | 296.50 | 1.0253 | 1.0461 |
| BT-20 | PLX-4720 | 0.31623 | uM | 4 | 312.50 | 138.79 | 356.00 | 296.50 | 1.2007 | 1.3635 |
| BT-20 | NVP-TAE684 | 0.031623 | uM | 4 | 312.50 | 138.79 | 343.00 | 296.50 | 1.1568 | 1.2846 |
| BT-20 | Nilotinib | 0.31623 | uM | 4 | 312.50 | 138.79 | 360.00 | 296.50 | 1.2142 | 1.3877 |
| BT-20 | NVP-TAE684 | 1 | uM | 4 | 312.50 | 138.79 | 222.00 | 296.50 | 0.7487 | 0.5356 |
| BT-20 | Etoposide | 0.031623 | uM | 4 | 312.50 | 138.79 | 273.00 | 296.50 | 0.9207 | 0.8547 |
| BT-20 | PLX-4720 | 1 | uM | 4 | 312.50 | 138.79 | 285.00 | 296.50 | 0.9612 | 0.9290 |
| BT-20 | PLX-4720 | 0.031623 | uM | 4 | 312.50 | 138.79 | 362.00 | 296.50 | 1.2209 | 1.3999 |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 281.00 | 296.50 | 0.9477 | 0.9043 | |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 187.00 | 296.50 | 0.6307 | 0.3129 | |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 206.00 | 296.50 | 0.6948 | 0.4342 | |
| BT-20 | 0 | uM | 4 | 312.50 | 138.79 | 279.00 | 296.50 | 0.9410 | 0.8919 | |
| BT-20 | Etoposide | 0.01 | uM | 4 | 312.50 | 138.79 | 289.00 | 296.50 | 0.9747 | 0.9538 |
| BT-20 | Etoposide | 0.31623 | uM | 4 | 312.50 | 138.79 | 234.00 | 296.50 | 0.7892 | 0.6112 |
| BT-20 | PLX-4720 | 0.1 | uM | 4 | 312.50 | 138.79 | 453.00 | 296.50 | 1.5278 | 1.9452 |
| BT-20 | Nilotinib | 0.01 | uM | 4 | 312.50 | 138.79 | 335.00 | 296.50 | 1.1298 | 1.2359 |
| BT-20 | Nilotinib | 0.1 | uM | 4 | 312.50 | 138.79 | 362.00 | 296.50 | 1.2209 | 1.3999 |
| BT-20 | Etoposide | 19.9526 | uM | 4 | 312.50 | 138.79 | 124.00 | 296.50 | 0.4182 | -0.0978 |
| BT-20 | PLX-4720 | 0.01 | uM | 4 | 312.50 | 138.79 | 299.00 | 296.50 | 1.0084 | 1.0154 |
| BT-20 | PLX-4720 | 3.1623 | uM | 4 | 312.50 | 138.79 | 312.00 | 296.50 | 1.0523 | 1.0953 |
| BT-20 | Nilotinib | 10 | uM | 4 | 312.50 | 138.79 | 758.00 | 296.50 | 2.5565 | 3.7127 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 4 | 312.50 | 138.79 | 299.00 | 296.50 | 1.0084 | 1.0154 |
| BT-20 | Nilotinib | 1 | uM | 4 | 312.50 | 138.79 | 377.00 | 296.50 | 1.2715 | 1.4905 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 4 | 312.50 | 138.79 | 387.00 | 296.50 | 1.3052 | 1.5508 |
| BT-20 | PLX-4720 | 10 | uM | 4 | 312.50 | 138.79 | 281.00 | 296.50 | 0.9477 | 0.9043 |